BAFL Activators
Activators targeting BANF family member 2, in the context of chemical compounds, are primarily approached through indirect pathways, especially those influencing chromatin remodeling and epigenetic regulation. Given the involvement of BANF proteins in nuclear architecture and chromatin structure, histone deacetylase (HDAC) inhibitors represent a significant category of these indirect activators. Compounds like Trichostatin A, Vorinostat, Valproic Acid, Sodium Butyrate, MS-275 (Entinostat), SAHA (Vorinostat), Romidepsin, Panobinostat, and Belinostat function by inhibiting histone deacetylases, leading to changes in chromatin structure, which could in turn influence the activity of BANF family proteins. These changes in chromatin accessibility and structure can have wide-ranging effects on gene expression and nuclear processes, potentially impacting proteins involved in maintaining nuclear architecture.
Additionally, DNA methyltransferase inhibitors like 5-Azacytidine and Decitabine represent another class of indirect activators. By altering DNA methylation patterns, these compounds can induce changes in gene expression and chromatin organization, which may affect the function of BANF proteins. Sirtinol, targeting sirtuin histone deacetylases, also falls into this category, potentially impacting chromatin dynamics and nuclear architecture relevant to BANF family proteins.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, may indirectly affect chromatin remodeling processes associated with BANF proteins. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat, another histone deacetylase inhibitor, could potentially influence nuclear architecture related to BANF proteins. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic Acid, also a histone deacetylase inhibitor, may have an indirect impact on BANF family proteins through chromatin modification. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium Butyrate, a short-chain fatty acid and histone deacetylase inhibitor, might affect BANF proteins by altering chromatin structure. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, could indirectly influence BANF proteins via epigenetic modifications. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Decitabine, similar to 5-Azacytidine, may impact BANF proteins indirectly through DNA methylation changes. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
MS-275, a selective histone deacetylase inhibitor, potentially affects BANF proteins by modulating chromatin dynamics. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
Romidepsin, a cyclic peptide histone deacetylase inhibitor, could influence BANF proteins by altering chromatin architecture. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Panobinostat, a potent histone deacetylase inhibitor, may indirectly impact BANF family proteins through epigenetic mechanisms. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $153.00 $561.00 | ||
Belinostat, a histone deacetylase inhibitor, might affect the function of BANF proteins via chromatin remodeling. | ||||||